Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 28 November 2003:
Vol. 302. no. 5650, pp. 1519 - 1522
DOI: 10.1126/science.1090350
Prev | Table of Contents | Next

Review

Are We Ready for Pandemic Influenza?

Richard J. Webby and Robert G. Webster*

During the past year, the public has become keenly aware of the threat of emerging infectious diseases with the global spread of severe acute respiratory syndrome (SARS), the continuing threat of bioterrorism, the proliferation of West Nile virus, and the discovery of human cases of monkeypoxin the United States. At the same time, an old foe has again raised its head, reminding us that our worst nightmare may not be a new one. In 2003, highly pathogenic strains of avian influenza virus, including the H5N1 and H7N7 subtypes, again crossed from birds to humans and caused fatal disease. Direct avian-to-human influenza transmission was unknown before 1997. Have we responded to these threats by better preparing for emerging disease agents, or are we continuing to act only as crises arise? Here we consider progress to date in preparedness for an influenza pandemic and review what remains to be done. We conclude by prioritizing the remaining needs and exploring the reasons for our current lack of preparedness for an influenza pandemic.

Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA

* To whom correspondence should be addressed. E-mail: robert.webster{at}stjude.org

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Infection of HLA-DR1 Transgenic Mice with a Human Isolate of Influenza A Virus (H1N1) Primes a Diverse CD4 T-Cell Repertoire That Includes CD4 T Cells with Heterosubtypic Cross-Reactivity to Avian (H5N1) Influenza Virus.
K. A. Richards, F. A. Chaves, and A. J. Sant (2009)
J. Virol. 83, 6566-6577
   Abstract »    Full Text »    PDF »
Protective Role for Protease-Activated Receptor-2 against Influenza Virus Pathogenesis via an IFN-{gamma}-Dependent Pathway.
K. Khoufache, F. LeBouder, E. Morello, F. Laurent, S. Riffault, P. Andrade-Gordon, S. Boullier, P. Rousset, N. Vergnolle, and B. Riteau (2009)
J. Immunol. 182, 7795-7802
   Abstract »    Full Text »    PDF »
Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.
C. Guillonneau, J. D. Mintern, F.-X. Hubert, A. C. Hurt, G. S. Besra, S. Porcelli, I. G. Barr, P. C. Doherty, D. I. Godfrey, and S. J. Turner (2009)
PNAS 106, 3330-3335
   Abstract »    Full Text »    PDF »
Mutational Analysis of cis-Acting RNA Signals in Segment 7 of Influenza A Virus.
E. C. Hutchinson, M. D. Curran, E. K. Read, J. R. Gog, and P. Digard (2008)
J. Virol. 82, 11869-11879
   Abstract »    Full Text »    PDF »
Multimerization of Surfactant Protein D, but Not Its Collagen Domain, Is Required for Antiviral and Opsonic Activities Related to Influenza Virus.
M. White, P. Kingma, T. Tecle, N. Kacak, B. Linders, J. Heuser, E. Crouch, and K. Hartshorn (2008)
J. Immunol. 181, 7936-7943
   Abstract »    Full Text »    PDF »
High-Throughput Screening of a 100,000-Compound Library for Inhibitors of Influenza A Virus (H3N2).
W. E. Severson, M. McDowell, S. Ananthan, D.-H. Chung, L. Rasmussen, M. I. Sosa, E. L. White, J. Noah, and C. B. Jonsson (2008)
J Biomol Screen 13, 879-887
   Abstract »    PDF »
Development of an HTS Assay for the Search of Anti-influenza Agents Targeting the Interaction of Viral RNA with the NS1 Protein.
M. Maroto, Y. Fernandez, J. Ortin, F. Pelaez, and M. A. Cabello (2008)
J Biomol Screen 13, 581-590
   Abstract »    PDF »
Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus.
C.-J. Wei, L. Xu, W.-P. Kong, W. Shi, K. Canis, J. Stevens, Z.-Y. Yang, A. Dell, S. M. Haslam, I. A. Wilson, et al. (2008)
J. Virol. 82, 6200-6208
   Abstract »    Full Text »    PDF »
Antiviral treatment for the control of pandemic influenza: some logistical constraints.
N Arinaminpathy and A.R McLean (2008)
J R Soc Interface 5, 545-553
   Abstract »    Full Text »    PDF »
Pattern Recognition Molecule Mindin Promotes Intranasal Clearance of Influenza Viruses.
W. Jia, H. Li, and Y.-W. He (2008)
J. Immunol. 180, 6255-6261
   Abstract »    Full Text »    PDF »
Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus.
C. Pappas, P. V. Aguilar, C. F. Basler, A. Solorzano, H. Zeng, L. A. Perrone, P. Palese, A. Garcia-Sastre, J. M. Katz, and T. M. Tumpey (2008)
PNAS 105, 3064-3069
   Abstract »    Full Text »    PDF »
Healthy Human Subjects Have CD4+ T Cells Directed against H5N1 Influenza Virus.
M. Roti, J. Yang, D. Berger, L. Huston, E. A. James, and W. W. Kwok (2008)
J. Immunol. 180, 1758-1768
   Abstract »    Full Text »    PDF »
Protective effect of low-concentration chlorine dioxide gas against influenza A virus infection.
N. Ogata and T. Shibata (2008)
J. Gen. Virol. 89, 60-67
   Abstract »    Full Text »    PDF »
The effect of population structure on the emergence of drug resistance during influenza pandemics.
F. Debarre, S. Bonhoeffer, and R. R Regoes (2007)
J R Soc Interface 4, 893-906
   Abstract »    Full Text »    PDF »
A quantitative genotype algorithm reflecting H5N1 Avian influenza niches.
X.-F. Wan, G. Chen, F. Luo, M. Emch, and R. Donis (2007)
Bioinformatics 23, 2368-2375
   Abstract »    Full Text »    PDF »
Prevalence of avian influenza and host ecology.
L. Z. Garamszegi and A. P. Moller (2007)
Proc R Soc B 274, 2003-2012
   Abstract »    Full Text »    PDF »
Direct Ex Vivo Analyses of HLA-DR1 Transgenic Mice Reveal an Exceptionally Broad Pattern of Immunodominance in the Primary HLA-DR1-Restricted CD4 T-Cell Response to Influenza Virus Hemagglutinin.
K. A. Richards, F. A. Chaves, F. R. Krafcik, D. J. Topham, C. A. Lazarski, and A. J. Sant (2007)
J. Virol. 81, 7608-7619
   Abstract »    Full Text »    PDF »
Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines.
J. B. Alarcon, A. W. Hartley, N. G. Harvey, and J. A. Mikszta (2007)
Clin. Vaccine Immunol. 14, 375-381
   Abstract »    Full Text »    PDF »
Task Force IV: Cardiovascular Effects of Emerging Infectious Diseases and Biological Terrorism Threats: Basic, Clinical, and Population Science Research and Training Needs.
M. Madjid, R. V. Luepker, K. J. Greenlund, K. A. Taubert, M. J. Roy, and R. M. Robertson (2007)
J. Am. Coll. Cardiol. 49, 1407-1412
   Full Text »    PDF »
Codon conservation in the influenza A virus genome defines RNA packaging signals.
J. R. Gog, E. D. S. Afonso, R. M. Dalton, I. Leclercq, L. Tiley, D. Elton, J. C. von Kirchbach, N. Naffakh, N. Escriou, and P. Digard (2007)
Nucleic Acids Res. 35, 1897-1907
   Abstract »    Full Text »    PDF »
Amelioration of Influenza Virus Pathogenesis in Chickens Attributed to the Enhanced Interferon-Inducing Capacity of a Virus with a Truncated NS1 Gene.
A. N. Cauthen, D. E. Swayne, M. J. Sekellick, P. I. Marcus, and D. L. Suarez (2007)
J. Virol. 81, 1838-1847
   Abstract »    Full Text »    PDF »
From the Cover: Predicting the global spread of H5N1 avian influenza.
A. M. Kilpatrick, A. A. Chmura, D. W. Gibbons, R. C. Fleischer, P. P. Marra, and P. Daszak (2006)
PNAS 103, 19368-19373
   Abstract »    Full Text »    PDF »
The evolutionary emergence of pandemic influenza.
T. Day, J.-B. Andre, and A. Park (2006)
Proc R Soc B 273, 2945-2953
   Abstract »    Full Text »    PDF »
Integrated Molecular Signature of Disease: Analysis of Influenza Virus-Infected Macaques through Functional Genomics and Proteomics.
T. Baas, C. R. Baskin, D. L. Diamond, A. Garcia-Sastre, H. Bielefeldt-Ohmann, T. M. Tumpey, M. J. Thomas, V. S. Carter, T. H. Teal, N. Van Hoeven, et al. (2006)
J. Virol. 80, 10813-10828
   Abstract »    Full Text »    PDF »
Key strategies for reducing spread of avian influenza among commercial poultry holdings: lessons for transmission to humans.
A. Le Menach, E. Vergu, R. F Grais, D. L Smith, and A. Flahault (2006)
Proc R Soc B 273, 2467-2475
   Abstract »    Full Text »    PDF »
Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza..
V. C. Huber, R. M. McKeon, M. N. Brackin, L. A. Miller, R. Keating, S. A. Brown, N. Makarova, D. R. Perez, G. H. MacDonald, and J. A. McCullers (2006)
Clin. Vaccine Immunol. 13, 981-990
   Abstract »    Full Text »    PDF »
Insights into the Interaction between Influenza Virus and Pneumococcus.
J. A. McCullers (2006)
Clin. Microbiol. Rev. 19, 571-582
   Abstract »    Full Text »    PDF »
Epidemic dynamics and antigenic evolution in a single season of influenza A.
M. F Boni, J. R Gog, V. Andreasen, and M. W Feldman (2006)
Proc R Soc B 273, 1307-1316
   Abstract »    Full Text »    PDF »
Innate Defense against Influenza A Virus: Activity of Human Neutrophil Defensins and Interactions of Defensins with Surfactant Protein D..
K. L. Hartshorn, M. R. White, T. Tecle, U. Holmskov, and E. C. Crouch (2006)
J. Immunol. 176, 6962-6972
   Abstract »    Full Text »    PDF »
Amelioration of Influenza-Induced Pathology in Mice by Coinfection with Trichinella spiralis.
R. C. Furze, T. Hussell, and M. E. Selkirk (2006)
Infect. Immun. 74, 1924-1932
   Abstract »    Full Text »    PDF »
Comparison of the Replication of Influenza A Viruses in Chinese Ring-Necked Pheasants and Chukar Partridges.
J. Humberd, Y. Guan, and R. G. Webster (2006)
J. Virol. 80, 2151-2161
   Abstract »    Full Text »    PDF »
Immunogenicity of Fowlpox Virus Expressing the Avian Influenza Virus H5 Gene (TROVAC AIV-H5) in Cats.
K. Karaca, D. E. Swayne, D. Grosenbaugh, M. Bublot, A. Robles, E. Spackman, and R. Nordgren (2005)
Clin. Vaccine Immunol. 12, 1340-1342
   Abstract »    Full Text »    PDF »
Public Health Approach to Emerging Infections Among Pregnant Women.
S. A. Rasmussen and E. B. Hayes (2005)
Am J Public Health 95, 1942-1944
   Abstract »    Full Text »    PDF »
Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus.
T. M. Tumpey, C. F. Basler, P. V. Aguilar, H. Zeng, A. Solorzano, D. E. Swayne, N. J. Cox, J. M. Katz, J. K. Taubenberger, P. Palese, et al. (2005)
Science 310, 77-80
   Abstract »    Full Text »    PDF »
Avian influenza A (H5N1) infection in humans..
J. H. Beigel (2005)
N. Engl. J. Med. 353, 1374-1385
   Full Text »    PDF »
Molecular Basis of Replication of Duck H5N1 Influenza Viruses in a Mammalian Mouse Model.
Z. Li, H. Chen, P. Jiao, G. Deng, G. Tian, Y. Li, E. Hoffmann, R. G. Webster, Y. Matsuoka, and K. Yu (2005)
J. Virol. 79, 12058-12064
   Abstract »    Full Text »    PDF »
Highly Pathogenic H5N1 Influenza Virus Infection in Migratory Birds.
J. Liu, H. Xiao, F. Lei, Q. Zhu, K. Qin, X.-w. Zhang, X.-l. Zhang, D. Zhao, G. Wang, Y. Feng, et al. (2005)
Science 309, 1206
   Abstract »    Full Text »    PDF »
Containing Pandemic Influenza at the Source.
I. M. Longini Jr., A. Nizam, S. Xu, K. Ungchusak, W. Hanshaoworakul, D. A. T. Cummings, and M. E. Halloran (2005)
Science 309, 1083-1087
   Abstract »    Full Text »    PDF »
'Genome gating'; polarized intranuclear trafficking of influenza virus RNPs.
D. Elton, M. J. Amorim, L. Medcalf, and P. Digard (2005)
Biol Lett 1, 113-117
   Abstract »    Full Text »    PDF »
Universal Influenza B Vaccine Based on the Maturational Cleavage Site of the Hemagglutinin Precursor.
E. Bianchi, X. Liang, P. Ingallinella, M. Finotto, M. A. Chastain, J. Fan, T.-M. Fu, H. C. Song, M. S. Horton, D. C. Freed, et al. (2005)
J. Virol. 79, 7380-7388
   Abstract »    Full Text »    PDF »
Laboratory-Based Surveillance and Molecular Epidemiology of Influenza Virus in Taiwan.
S.-R. Shih, G.-W. Chen, C.-C. Yang, W.-Z. Yang, D.-P. Liu, J.-H. Lin, S.-C. Chiu, H.-Y. Chen, K.-C. Tsao, C.-G. Huang, et al. (2005)
J. Clin. Microbiol. 43, 1651-1661
   Abstract »    Full Text »    PDF »
Evaluation of PCR Testing of Ethanol-Fixed Nasal Swab Specimens as an Augmented Surveillance Strategy for Influenza Virus and Adenovirus Identification.
A. E. Krafft, K. L. Russell, A. W. Hawksworth, S. McCall, M. Irvine, L. T. Daum, J. L. Connoly, A. H. Reid, J. C. Gaydos, and J. K. Taubenberger (2005)
J. Clin. Microbiol. 43, 1768-1775
   Abstract »    Full Text »    PDF »
Detection of Human Influenza A Viruses by Loop-Mediated Isothermal Amplification.
L. L. M. Poon, C. S. W. Leung, K. H. Chan, J. H. C. Lee, K. Y. Yuen, Y. Guan, and J. S. M. Peiris (2005)
J. Clin. Microbiol. 43, 427-430
   Abstract »    Full Text »    PDF »
Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium.
M. N. Matrosovich, T. Y. Matrosovich, T. Gray, N. A. Roberts, and H.-D. Klenk (2004)
J. Virol. 78, 12665-12667
   Abstract »    Full Text »    PDF »
Health and economic benefits of an accelerated program of research to combat global infectious diseases.
Global IDEA Scientific Advisory Committee (2004)
Can. Med. Assoc. J. 171, 1203-1208
   Full Text »    PDF »
Emerging Infectious Diseases: A Clear and Present Danger to Humanity.
A. S. Fauci (2004)
JAMA 292, 1887-1888
   Full Text »    PDF »
Avian H5N1 Influenza in Cats.
T. Kuiken, G. Rimmelzwaan, D. van Riel, G. van Amerongen, M. Baars, R. Fouchier, and A. Osterhaus (2004)
Science 306, 241
   Abstract »    Full Text »    PDF »
Avian influenza: a human pandemic threat?.
G. Rezza (2004)
J Epidemiol Community Health 58, 807-808
   Full Text »    PDF »
Influenza: Emergence and Control.
A. S. Lipatov, E. A. Govorkova, R. J. Webby, H. Ozaki, M. Peiris, Y. Guan, L. Poon, and R. G. Webster (2004)
J. Virol. 78, 8951-8959
   Full Text »    PDF »
The evolution of H5N1 influenza viruses in ducks in southern China.
H. Chen, G. Deng, Z. Li, G. Tian, Y. Li, P. Jiao, L. Zhang, Z. Liu, R. G. Webster, and K. Yu (2004)
PNAS 101, 10452-10457
   Abstract »    Full Text »    PDF »
Waiting for the flu.
C. Berry (2004)
QJM 97, 311-312
   Full Text »    PDF »
Containing Pandemic Influenza with Antiviral Agents.
I. M. Longini Jr., M. E. Halloran, A. Nizam, and Y. Yang (2004)
Am. J. Epidemiol. 159, 623-633
   Abstract »    Full Text »    PDF »
Avian Influenza: A New Pandemic Threat?.
A. Trampuz, R. M. Prabhu, T. F. Smith, and L. M. Baddour (2004)
Mayo Clin. Proc. 79, 523-530
   Abstract »    PDF »
Structure of the Uncleaved Human H1 Hemagglutinin from the Extinct 1918 Influenza Virus.
J. Stevens, A. L. Corper, C. F. Basler, J. K. Taubenberger, P. Palese, and I. A. Wilson (2004)
Science 303, 1866-1870
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)